AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] The Chemours Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 08/01/2025, Chemours (CC) President & CEO Denise Dignam filed a Form 4 disclosing an automatic share withholding (Transaction Code F) tied to vested restricted stock units.

  • Shares withheld: 466 common shares at $11.50, executed solely to satisfy tax obligations; no open-market sale occurred and the trade is Rule 16b-3 exempt.
  • Remaining ownership: 187,478.1549 shares held directly, meaning the transaction reduced her stake by roughly 0.25%.
  • Insider role: Dignam serves as both President & CEO and Director, maintaining substantial equity alignment with investors.

The event is routine, immaterial to Chemours� capital structure and does not signal a change in insider sentiment.

Il 01/08/2025, Denise Dignam, Presidente e CEO di Chemours (CC), ha presentato un Modulo 4 che dichiara una trattenuta automatica di azioni (Codice Transazione F) relativa a unità azionarie vincolate maturate.

  • Azioni trattenute: 466 azioni ordinarie a 11,50 $, eseguite esclusivamente per soddisfare obblighi fiscali; non è avvenuta alcuna vendita sul mercato aperto e l’operazione è esente dalla Regola 16b-3.
  • Quota residua posseduta: 187.478,1549 azioni detenute direttamente, con una riduzione della partecipazione di circa lo 0,25%.
  • Ruolo interno: Dignam ricopre sia la carica di Presidente e CEO sia quella di Direttore, mantenendo un significativo allineamento di interessi con gli investitori.

L’evento è di routine, irrilevante per la struttura del capitale di Chemours e non indica un cambiamento nel sentimento degli insider.

El 01/08/2025, Denise Dignam, Presidenta y CEO de Chemours (CC), presentó un Formulario 4 que revela una retención automática de acciones (Código de Transacción F) vinculada a unidades restringidas de acciones consolidadas.

  • Acciones retenidas: 466 acciones comunes a 11,50 $, realizadas únicamente para cumplir obligaciones fiscales; no se efectuó ninguna venta en el mercado abierto y la operación está exenta bajo la Regla 16b-3.
  • Participación restante: 187.478,1549 acciones en propiedad directa, lo que representa una reducción aproximada del 0,25% en su participación.
  • Rol interno: Dignam desempeña los cargos de Presidenta, CEO y Directora, manteniendo una alineación significativa con los intereses de los inversionistas.

El evento es rutinario, sin impacto material en la estructura de capital de Chemours y no indica un cambio en el sentimiento de los insiders.

2025ë…� 8ì›� 1ì�, Chemours(CC)ì� 사장 ê²� CEOì� Denise Dignamì� ì–‘ë„ ì œí•œ ì£¼ì‹ ë‹¨ìœ„ ì·¨ë“ê³� ê´€ë ¨ëœ ìžë™ ì£¼ì‹ ì›ì²œì§•수(거래 코드 F)ë¥� 신고하는 Form 4ë¥� 제출했습니다.

  • ì›ì²œì§•수ë� 주ì‹: 세금 ì˜ë¬´ë¥� 충족하기 위해 11.50달러ì—� 466ì£� 보통주가 ì›ì²œì§•수ë˜ì—ˆìœ¼ë©°, 공개 시장ì—서ì� 매ë„ëŠ� 없었ê³� ì� 거래ëŠ� Rule 16b-3 ë©´ì œ 대ìƒìž…니다.
  • 잔여 소유 주ì‹: ì§ì ‘ 보유 ì¤‘ì¸ 187,478.1549주로, ì´ë²ˆ 거래ë¡� ì•� 0.25% ì§€ë¶„ì´ ê°ì†Œí–ˆìŠµë‹ˆë‹¤.
  • ë‚´ë¶€ìž� ì—­í• : Dignamì€ ì‚¬ìž¥ ê²� CEOì´ìž ì´ì‚¬ë¡œì„œ 투ìžìžë“¤ê³� ìƒë‹¹í•� ì§€ë¶� ì •ë ¬ì� 유지하고 있습니다.

ì´ë²ˆ ì‚¬ê±´ì€ ì¼ìƒì ì¸ 것으ë¡� Chemoursì� ìžë³¸ 구조ì—� 미미í•� ì˜í–¥ë§� 있으ë©� ë‚´ë¶€ìžì˜ 심리 ë³€í™� 신호가 아닙니다.

Le 01/08/2025, Denise Dignam, Présidente et CEO de Chemours (CC), a déposé un formulaire 4 révélant une retenue automatique d’actions (code transaction F) liée à des unités d’actions restreintes acquises.

  • Actions retenues : 466 actions ordinaires à 11,50 $, effectuées uniquement pour satisfaire des obligations fiscales ; aucune vente sur le marché ouvert n’a eu lieu et la transaction est exonérée selon la règle 16b-3.
  • Participation restante : 187 478,1549 actions détenues directement, ce qui représente une réduction d’environ 0,25 % de sa participation.
  • Rôle d’initié : Dignam occupe les postes de Présidente, CEO et Administratrice, maintenant un alignement significatif avec les investisseurs.

L’événement est de routine, sans incidence matérielle sur la structure du capital de Chemours et ne signale aucun changement dans le sentiment des initiés.

Am 01.08.2025 reichte Denise Dignam, Präsidentin & CEO von Chemours (CC), ein Formular 4 ein, das eine automatische Aktieneinbehaltung (Transaktionscode F) im Zusammenhang mit unverfallbaren Restricted Stock Units offenlegt.

  • Zurückbehaltene Aktien: 466 Stammaktien zu 11,50 $, ausschließlich zur Erfüllung von Steuerverpflichtungen; kein Verkauf am offenen Markt, und die Transaktion ist von Regel 16b-3 ausgenommen.
  • Verbleibender Besitz: 187.478,1549 direkt gehaltene Aktien, was einer Reduzierung ihres Anteils um etwa 0,25 % entspricht.
  • Insider-Rolle: Dignam ist sowohl Präsidentin & CEO als auch Direktorin und hält somit eine bedeutende Eigenkapitalausrichtung mit den Investoren aufrecht.

Das Ereignis ist routinemäßig, ohne wesentliche Auswirkung auf die Kapitalstruktur von Chemours und signalisiert keine Änderung der Insider-Stimmung.

Positive
  • None.
Negative
  • None.

Insights

TL;DR � Routine tax-withholding; no change in investment thesis.

This Form 4 shows a standard, non-discretionary withholding of 466 shares to cover taxes on vested RSUs. Dignam still holds about 187.5 k shares, so the dilution is de minimis and offers no directional signal regarding Chemours� fundamentals or stock outlook.

TL;DR � Governance neutral; equity alignment intact.

Code F transactions are exempt and routine. No shares were sold, preserving insider alignment. The filing demonstrates compliance with Section 16 reporting obligations but carries negligible governance or market impact.

Il 01/08/2025, Denise Dignam, Presidente e CEO di Chemours (CC), ha presentato un Modulo 4 che dichiara una trattenuta automatica di azioni (Codice Transazione F) relativa a unità azionarie vincolate maturate.

  • Azioni trattenute: 466 azioni ordinarie a 11,50 $, eseguite esclusivamente per soddisfare obblighi fiscali; non è avvenuta alcuna vendita sul mercato aperto e l’operazione è esente dalla Regola 16b-3.
  • Quota residua posseduta: 187.478,1549 azioni detenute direttamente, con una riduzione della partecipazione di circa lo 0,25%.
  • Ruolo interno: Dignam ricopre sia la carica di Presidente e CEO sia quella di Direttore, mantenendo un significativo allineamento di interessi con gli investitori.

L’evento è di routine, irrilevante per la struttura del capitale di Chemours e non indica un cambiamento nel sentimento degli insider.

El 01/08/2025, Denise Dignam, Presidenta y CEO de Chemours (CC), presentó un Formulario 4 que revela una retención automática de acciones (Código de Transacción F) vinculada a unidades restringidas de acciones consolidadas.

  • Acciones retenidas: 466 acciones comunes a 11,50 $, realizadas únicamente para cumplir obligaciones fiscales; no se efectuó ninguna venta en el mercado abierto y la operación está exenta bajo la Regla 16b-3.
  • Participación restante: 187.478,1549 acciones en propiedad directa, lo que representa una reducción aproximada del 0,25% en su participación.
  • Rol interno: Dignam desempeña los cargos de Presidenta, CEO y Directora, manteniendo una alineación significativa con los intereses de los inversionistas.

El evento es rutinario, sin impacto material en la estructura de capital de Chemours y no indica un cambio en el sentimiento de los insiders.

2025ë…� 8ì›� 1ì�, Chemours(CC)ì� 사장 ê²� CEOì� Denise Dignamì� ì–‘ë„ ì œí•œ ì£¼ì‹ ë‹¨ìœ„ ì·¨ë“ê³� ê´€ë ¨ëœ ìžë™ ì£¼ì‹ ì›ì²œì§•수(거래 코드 F)ë¥� 신고하는 Form 4ë¥� 제출했습니다.

  • ì›ì²œì§•수ë� 주ì‹: 세금 ì˜ë¬´ë¥� 충족하기 위해 11.50달러ì—� 466ì£� 보통주가 ì›ì²œì§•수ë˜ì—ˆìœ¼ë©°, 공개 시장ì—서ì� 매ë„ëŠ� 없었ê³� ì� 거래ëŠ� Rule 16b-3 ë©´ì œ 대ìƒìž…니다.
  • 잔여 소유 주ì‹: ì§ì ‘ 보유 ì¤‘ì¸ 187,478.1549주로, ì´ë²ˆ 거래ë¡� ì•� 0.25% ì§€ë¶„ì´ ê°ì†Œí–ˆìŠµë‹ˆë‹¤.
  • ë‚´ë¶€ìž� ì—­í• : Dignamì€ ì‚¬ìž¥ ê²� CEOì´ìž ì´ì‚¬ë¡œì„œ 투ìžìžë“¤ê³� ìƒë‹¹í•� ì§€ë¶� ì •ë ¬ì� 유지하고 있습니다.

ì´ë²ˆ ì‚¬ê±´ì€ ì¼ìƒì ì¸ 것으ë¡� Chemoursì� ìžë³¸ 구조ì—� 미미í•� ì˜í–¥ë§� 있으ë©� ë‚´ë¶€ìžì˜ 심리 ë³€í™� 신호가 아닙니다.

Le 01/08/2025, Denise Dignam, Présidente et CEO de Chemours (CC), a déposé un formulaire 4 révélant une retenue automatique d’actions (code transaction F) liée à des unités d’actions restreintes acquises.

  • Actions retenues : 466 actions ordinaires à 11,50 $, effectuées uniquement pour satisfaire des obligations fiscales ; aucune vente sur le marché ouvert n’a eu lieu et la transaction est exonérée selon la règle 16b-3.
  • Participation restante : 187 478,1549 actions détenues directement, ce qui représente une réduction d’environ 0,25 % de sa participation.
  • Rôle d’initié : Dignam occupe les postes de Présidente, CEO et Administratrice, maintenant un alignement significatif avec les investisseurs.

L’événement est de routine, sans incidence matérielle sur la structure du capital de Chemours et ne signale aucun changement dans le sentiment des initiés.

Am 01.08.2025 reichte Denise Dignam, Präsidentin & CEO von Chemours (CC), ein Formular 4 ein, das eine automatische Aktieneinbehaltung (Transaktionscode F) im Zusammenhang mit unverfallbaren Restricted Stock Units offenlegt.

  • Zurückbehaltene Aktien: 466 Stammaktien zu 11,50 $, ausschließlich zur Erfüllung von Steuerverpflichtungen; kein Verkauf am offenen Markt, und die Transaktion ist von Regel 16b-3 ausgenommen.
  • Verbleibender Besitz: 187.478,1549 direkt gehaltene Aktien, was einer Reduzierung ihres Anteils um etwa 0,25 % entspricht.
  • Insider-Rolle: Dignam ist sowohl Präsidentin & CEO als auch Direktorin und hält somit eine bedeutende Eigenkapitalausrichtung mit den Investoren aufrecht.

Das Ereignis ist routinemäßig, ohne wesentliche Auswirkung auf die Kapitalstruktur von Chemours und signalisiert keine Änderung der Insider-Stimmung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dignam Denise

(Last) (First) (Middle)
C/O THE CHEMOURS COMPANY
1007 MARKET STREET

(Street)
WILMINGTON DE 19801

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 F(1) 466 D $11.5 187,478.1549(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
2. Includes directly owned shares, restricted stock units and dividend equivalent units.
Remarks:
Power of Attorney attached as Exhibit 24.
/s/ Eric Stein, Attorney-in-Fact 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What type of transaction did Chemours (CC) file?

A Form 4 reporting an automatic tax-withholding (Code F) related to vested restricted stock units.

How many Chemours shares were withheld for taxes?

466 common shares at a reference price of $11.50.

How many Chemours shares does CEO Denise Dignam now own?

She holds 187,478.1549 shares directly after the transaction.

Was this an open-market sale of Chemours stock?

No. The shares were automatically withheld to cover taxes; no discretionary sale occurred.

Does this Form 4 impact Chemours� outlook?

The withholding is routine and immaterial; it does not affect the company’s fundamentals or investment thesis.
Chemours Co

NYSE:CC

CC Rankings

CC Latest News

CC Latest SEC Filings

CC Stock Data

1.89B
148.90M
0.47%
98.78%
10.69%
Specialty Chemicals
Chemicals & Allied Products
United States
WILMINGTON